In the last general session of this year’s San Antonio breast cancer...
Dr Karen Van Baelen, a PhD researcher at the KULeuven, is currently doing a...
Dr Edoardo Isnaldi and François Richard, both working at the Laboratory of...
Prof Duhoux from the oncology department of the King Albert II institute of the...
Invasive lobular breast carcinoma (ILC) represents 5 to 15% of all invasive...
The POLAR signature is a genetic classifier to define benefit of breast cancer...
Day 4 at the San Antonio Breast Cancer Symposium (SABCS) is summarised here by...
The levonorgestrel intra-uterine device (LNG-IUD) is a widely used...
The 4-year follow up data of a pre-planned overall survival analysis of the...
Day 3 at the San Antonio Breast Cancer Symposium (SABCS) focused on endocrine...